| Dr Benjamin Clark Pease, MD | |
|
4201 Anderson Ave, Bldg. C, Manhattan, KS 66503-7601 | |
| (785) 539-3504 | |
| (785) 539-7430 |
| Full Name | Dr Benjamin Clark Pease |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 33 Years |
| Location | 4201 Anderson Ave, Manhattan, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952308082 | NPI | - | NPPES |
| 100288270B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 04-26124 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Manhattan Surgical Hospital Llc | Manhattan, KS | Hospital |
| Ascension Via Christi Hospital Manhattain, Inc | Manhattan, KS | Hospital |
| Salina Surgical Hospital | Salina, KS | Hospital |
| Salina Regional Health Center | Salina, KS | Hospital |
| Community Memorial Healthcare, Inc. | Marysville, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inspire Ent And Pulmonology Pa | 2466405568 | 12 |
News Archive
A new study published on the medRxiv* preprint server used automated high content immunofluorescence microscopy (AHCIM) to assess the viability of such an approach to detect humoral immune responses against SARS-CoV-2 proteins.
Johns Hopkins neurosurgeon Alfredo Quinones-Hinojosa has been awarded the Cortes de Cadiz Prize in the category of surgery by the city council of Cadiz, Spain. The jury prize, in which members of the Royal Academy of Medicine and Surgery took part, was awarded to Quinones-Hinojosa not only for his renowned scientific career but also for his "moving life experience," which, the judges noted, is full of "self-improvement and success."
The following is a statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids: A study published Thursday by the American Journal of Public Health provides some of the strongest evidence yet that tobacco prevention and cessation programs not only reduce smoking and save lives, but also save money by reducing tobacco-related health care costs.
Recording electrical signals from inside a neuron in the living brain can reveal a great deal of information about that neuron's function and how it coordinates with other cells in the brain.
Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.
› Verified 2 days ago
| Entity Name | Inspire Ent And Pulmonology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891777603 PECOS PAC ID: 2466405568 Enrollment ID: O20050301000767 |
News Archive
A new study published on the medRxiv* preprint server used automated high content immunofluorescence microscopy (AHCIM) to assess the viability of such an approach to detect humoral immune responses against SARS-CoV-2 proteins.
Johns Hopkins neurosurgeon Alfredo Quinones-Hinojosa has been awarded the Cortes de Cadiz Prize in the category of surgery by the city council of Cadiz, Spain. The jury prize, in which members of the Royal Academy of Medicine and Surgery took part, was awarded to Quinones-Hinojosa not only for his renowned scientific career but also for his "moving life experience," which, the judges noted, is full of "self-improvement and success."
The following is a statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids: A study published Thursday by the American Journal of Public Health provides some of the strongest evidence yet that tobacco prevention and cessation programs not only reduce smoking and save lives, but also save money by reducing tobacco-related health care costs.
Recording electrical signals from inside a neuron in the living brain can reveal a great deal of information about that neuron's function and how it coordinates with other cells in the brain.
Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin Clark Pease, MD 4201 Anderson Ave, Bldg. C, Manhattan, KS 66503-7601 Ph: (785) 539-3504 | Dr Benjamin Clark Pease, MD 4201 Anderson Ave, Bldg. C, Manhattan, KS 66503-7601 Ph: (785) 539-3504 |
News Archive
A new study published on the medRxiv* preprint server used automated high content immunofluorescence microscopy (AHCIM) to assess the viability of such an approach to detect humoral immune responses against SARS-CoV-2 proteins.
Johns Hopkins neurosurgeon Alfredo Quinones-Hinojosa has been awarded the Cortes de Cadiz Prize in the category of surgery by the city council of Cadiz, Spain. The jury prize, in which members of the Royal Academy of Medicine and Surgery took part, was awarded to Quinones-Hinojosa not only for his renowned scientific career but also for his "moving life experience," which, the judges noted, is full of "self-improvement and success."
The following is a statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids: A study published Thursday by the American Journal of Public Health provides some of the strongest evidence yet that tobacco prevention and cessation programs not only reduce smoking and save lives, but also save money by reducing tobacco-related health care costs.
Recording electrical signals from inside a neuron in the living brain can reveal a great deal of information about that neuron's function and how it coordinates with other cells in the brain.
Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.
› Verified 2 days ago